Completed Psychology & Behaviour Brain & Nervous System

Towards personalized cognitive brain stimulation for depression

In plain English

AI plain-English summary

Depression warps how people process good and bad news, and a new wave of brain stimulation treatments aims to correct that cognitive bias directly. Current non-invasive brain stimulation for depression—such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS)—targets broad brain regions like the dorsolateral prefrontal cortex, but response varies widely between patients. The researcher proposes a more precise approach: instead of using resting-state brain scans to pick a stimulation site, they will target two specific areas based on their cognitive roles. The dorsomedial prefrontal cortex (DMPFC) will be stimulated to boost learning from positive outcomes, while the lateral orbitofrontal cortex (LOFC) will be stimulated to reduce inappropriate self-blame for negative outcomes. This is grounded in the theory that effective depression treatments work by rapidly reducing negative cognitive biases, and that mood improvement over time depends on reinforcement learning. If this proof-of-concept succeeds, it could transform brain stimulation from a one-size-fits-all procedure into a personalised therapy that targets the specific cognitive distortions driving a patient’s depression. The immediate impact would be on clinical practice—offering a more rational, mechanism-based way to select stimulation targets—rather than on everyday infrastructure. This is fundamental science: establishing whether cognitive targeting can improve treatment outcomes, with the long-term goal of making depression therapy faster and more reliable.

View original technical description
Non-invasive brain stimulation is a new family of treatments for depression. Efficacy is established for TMS to dorsolateral prefrontal cortex and under evaluation for tDCS. Recently efficacy has emerged for two additional targets: dorsomedial prefrontal (DMPFC) and lateral orbitofrontal cortex (LOFC). In the current state of the art, resting-state neuroimaging is being tested to personalize TMS target selection. My vision is to further improve treatment by targeting stimulation based on cognitive function. My project aims to lay the scientific foundations to achieve this. In depression, cognition and emotion are biased towards negative information. According to theory, when drugs and cognitive therapies work, they do so by rapidly reducing negative bias. I will test if this cognitive mechanism mediates TMS treatment and explains individual differences in clinical response. With repeated treatment, people gradually experience the world more positively, which slowly improves mood. This is thought to depend on reinforcement learning. Using tDCS I will stimulate DMPFC to increase learning from positive outcomes. I will stimulate LOFC to reduce inappropriate self-blame for negative outcomes. My scientific aim is to establish proof of concept that this cognitive targeting will improve DMPFC and LOFC stimulation. My long-term goal is to improve treatment.

View the original record at the funder ↗

Researchers

Jacinta O'Shea (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Cognitive neurostimulation as an antidepressant strategy?
Effects of deep non-invasive brain stimulation on emotion, motivation and decision making
Exploring the physiology and behavioural relevance of circuits in the human motor cortex with a novel transcranial magnetic stimulation device
Non-invasive ultrasound neuromodulation of human goal-directed behaviour
Brainteract - Using brain imaging to understand the neural effects of integrated therapist and online cognitive behavioural therapy for the treatment of depression

Original classification

Sir Henry Dale Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.